Cargando…
Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
Various autoantibodies are seen in idiopathic inflammatory myopathies. Among myositis-specific antibodies, anti-aminoacyl-tRNA synthetase and anti-melanoma differentiation-associated protein 5 (MDA5) antibodies are associated with interstitial lung disease (ILD). Anti-MDA5 antibodies are associated...
Autor principal: | Yoshifuji, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820065/ https://www.ncbi.nlm.nih.gov/pubmed/27081322 http://dx.doi.org/10.4137/CCRPM.S36748 |
Ejemplares similares
-
Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Kawasumi, Hidenaga, et al.
Publicado: (2015) -
Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease
por: Cao, Heng, et al.
Publicado: (2022) -
Narrative review of autoantibodies in idiopathic inflammatory myopathies
por: Liu, Yilin, et al.
Publicado: (2021) -
Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
por: Stuhlmüller, Bruno, et al.
Publicado: (2019) -
Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)